Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 4,530 KRW
Change Today +445.00 / 10.89%
Volume 1.5M
As of 2:25 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

medifron dbt co ltd (065650) Snapshot

Open
4,095
Previous Close
4,085
Day High
4,670
Day Low
4,090
52 Week High
04/17/15 - 4,670
52 Week Low
12/2/14 - 2,355
Market Cap
111.8B
Average Volume 10 Days
612.8K
EPS TTM
-82.00
Shares Outstanding
24.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIFRON DBT CO LTD (065650)

Related News

No related news articles were found.

medifron dbt co ltd (065650) Related Businessweek News

No Related Businessweek News Found

medifron dbt co ltd (065650) Details

Medifron DBT Co Ltd provides contents to wire and wireless communication and portal site, community site, etc. in south Korea. Its offerings include wireless internet mobile contents development, software development and service, Internet service and consulting, wireless data service, Internet broadcasting, and telecommunications and other communication services. The company also distributes specialized LCD monitors, digital cameras and mouth, etc.; and manufactures and sells electric and electronic products, and computers and its accessories. In addition, Medifron DBT Co is involved in the research and development, manufacture, and sale of the medical products and bio engineering related products for the Alzheimer dementia remedy and non-narcotic analgesics, and the central nervous system disease remedy agent. Further, its activities include patent rights license lending and mediation, and the wholesale and retail sale of the merchandizes relating to the medical products or the reagent. The company was formerly known as Legend Technologies Inc. and changed its name to Medifron DBT Co., Ltd. in 2006. Medifron DBT Co Ltd was founded in 1997 and is headquartered in Seoul, South Korea.

Founded in 1997

medifron dbt co ltd (065650) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medifron dbt co ltd (065650) Key Developments

Medifron DBT Co Ltd, Annual General Meeting, Mar 27, 2015

Medifron DBT Co Ltd, Annual General Meeting, Mar 27, 2015., at 09:30 Korea Standard Time. Location: 3rd floor conference room of 3-5 (Yeomchang-dong, Rainforest Blue Nine Business Center). Agenda: To consider Audit report and Business report; to approve financial statements; to approve appointment of inside and outside directors; and to approve remuneration ceiling.

Medifron DBT Co Ltd, Annual General Meeting, Mar 27, 2014

Medifron DBT Co Ltd, Annual General Meeting, Mar 27, 2014., at 09:30 Korea Standard Time. Location: 95-9 Huh Gangseo-gu, Seoul. Agenda: To consider the financial statements approval; to consider the approval of directors' remuneration limit; and to consider the approval of audit fees limit.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
065650:KS 4,530.00 KRW +445.00

065650 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 065650.
View Industry Companies
 

Industry Analysis

065650

Industry Average

Valuation 065650 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 20.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIFRON DBT CO LTD, please visit www.medifron.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.